phase readout
saveNCT07423494: Personalized Antisense Oligonucleotide Therapy for A Single Patient With CHCHD10 ALS (nL18576)
NOT_YET_RECRUITINGupdated 15d ago
community read0 votes
Sponsor: n-Lorem Foundation. Phase: PHASE1. Conditions: Amyotrophic Lateral Sclerosis
view source ↗
comments(0)
5-min edit window · permanent after that